nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Splenomegaly—Varenicline—nicotine dependence	0.0952	0.0952	CcSEcCtD
Abacavir—Drug hypersensitivity—Varenicline—nicotine dependence	0.0656	0.0656	CcSEcCtD
Abacavir—Depressed mood—Varenicline—nicotine dependence	0.0591	0.0591	CcSEcCtD
Abacavir—Musculoskeletal pain—Varenicline—nicotine dependence	0.0267	0.0267	CcSEcCtD
Abacavir—Abnormal dreams—Varenicline—nicotine dependence	0.0261	0.0261	CcSEcCtD
Abacavir—Influenza like illness—Varenicline—nicotine dependence	0.0257	0.0257	CcSEcCtD
Abacavir—Mouth ulceration—Varenicline—nicotine dependence	0.0239	0.0239	CcSEcCtD
Abacavir—Lymphadenopathy—Varenicline—nicotine dependence	0.0225	0.0225	CcSEcCtD
Abacavir—Sleep disorder—Varenicline—nicotine dependence	0.0222	0.0222	CcSEcCtD
Abacavir—Lethargy—Varenicline—nicotine dependence	0.0196	0.0196	CcSEcCtD
Abacavir—Migraine—Varenicline—nicotine dependence	0.0189	0.0189	CcSEcCtD
Abacavir—Liver function test abnormal—Varenicline—nicotine dependence	0.0177	0.0177	CcSEcCtD
Abacavir—Abdominal pain upper—Varenicline—nicotine dependence	0.0175	0.0175	CcSEcCtD
Abacavir—Gastritis—Varenicline—nicotine dependence	0.017	0.017	CcSEcCtD
Abacavir—Bronchitis—Varenicline—nicotine dependence	0.0159	0.0159	CcSEcCtD
Abacavir—Abdominal discomfort—Varenicline—nicotine dependence	0.0159	0.0159	CcSEcCtD
Abacavir—Hyperglycaemia—Varenicline—nicotine dependence	0.015	0.015	CcSEcCtD
Abacavir—Depression—Varenicline—nicotine dependence	0.0147	0.0147	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0147	0.0147	CcSEcCtD
Abacavir—Acute coronary syndrome—Varenicline—nicotine dependence	0.0146	0.0146	CcSEcCtD
Abacavir—Myocardial infarction—Varenicline—nicotine dependence	0.0145	0.0145	CcSEcCtD
Abacavir—Stomatitis—Varenicline—nicotine dependence	0.0144	0.0144	CcSEcCtD
Abacavir—Conjunctivitis—Varenicline—nicotine dependence	0.0144	0.0144	CcSEcCtD
Abacavir—Hepatobiliary disease—Varenicline—nicotine dependence	0.014	0.014	CcSEcCtD
Abacavir—Connective tissue disorder—Varenicline—nicotine dependence	0.013	0.013	CcSEcCtD
Abacavir—Erythema multiforme—Varenicline—nicotine dependence	0.0125	0.0125	CcSEcCtD
Abacavir—Immune system disorder—Varenicline—nicotine dependence	0.012	0.012	CcSEcCtD
Abacavir—Chills—Varenicline—nicotine dependence	0.0119	0.0119	CcSEcCtD
Abacavir—Malnutrition—Varenicline—nicotine dependence	0.0116	0.0116	CcSEcCtD
Abacavir—Ill-defined disorder—Varenicline—nicotine dependence	0.0107	0.0107	CcSEcCtD
Abacavir—Anaemia—Varenicline—nicotine dependence	0.0107	0.0107	CcSEcCtD
Abacavir—Malaise—Varenicline—nicotine dependence	0.0104	0.0104	CcSEcCtD
Abacavir—Vertigo—Varenicline—nicotine dependence	0.0104	0.0104	CcSEcCtD
Abacavir—Cough—Varenicline—nicotine dependence	0.0101	0.0101	CcSEcCtD
Abacavir—Convulsion—Varenicline—nicotine dependence	0.01	0.01	CcSEcCtD
Abacavir—Arthralgia—Varenicline—nicotine dependence	0.00983	0.00983	CcSEcCtD
Abacavir—Myalgia—Varenicline—nicotine dependence	0.00983	0.00983	CcSEcCtD
Abacavir—Anxiety—Varenicline—nicotine dependence	0.0098	0.0098	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00977	0.00977	CcSEcCtD
Abacavir—Discomfort—Varenicline—nicotine dependence	0.00972	0.00972	CcSEcCtD
Abacavir—Oedema—Varenicline—nicotine dependence	0.00943	0.00943	CcSEcCtD
Abacavir—Infection—Varenicline—nicotine dependence	0.00936	0.00936	CcSEcCtD
Abacavir—Nervous system disorder—Varenicline—nicotine dependence	0.00924	0.00924	CcSEcCtD
Abacavir—Thrombocytopenia—Varenicline—nicotine dependence	0.00923	0.00923	CcSEcCtD
Abacavir—Skin disorder—Varenicline—nicotine dependence	0.00916	0.00916	CcSEcCtD
Abacavir—Anorexia—Varenicline—nicotine dependence	0.00899	0.00899	CcSEcCtD
Abacavir—Hypotension—Varenicline—nicotine dependence	0.00881	0.00881	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00859	0.00859	CcSEcCtD
Abacavir—Insomnia—Varenicline—nicotine dependence	0.00853	0.00853	CcSEcCtD
Abacavir—Dyspnoea—Varenicline—nicotine dependence	0.0084	0.0084	CcSEcCtD
Abacavir—Decreased appetite—Varenicline—nicotine dependence	0.00819	0.00819	CcSEcCtD
Abacavir—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00814	0.00814	CcSEcCtD
Abacavir—Fatigue—Varenicline—nicotine dependence	0.00813	0.00813	CcSEcCtD
Abacavir—Pain—Varenicline—nicotine dependence	0.00806	0.00806	CcSEcCtD
Abacavir—Feeling abnormal—Varenicline—nicotine dependence	0.00777	0.00777	CcSEcCtD
Abacavir—Gastrointestinal pain—Varenicline—nicotine dependence	0.00771	0.00771	CcSEcCtD
Abacavir—Urticaria—Varenicline—nicotine dependence	0.00749	0.00749	CcSEcCtD
Abacavir—Body temperature increased—Varenicline—nicotine dependence	0.00745	0.00745	CcSEcCtD
Abacavir—Abdominal pain—Varenicline—nicotine dependence	0.00745	0.00745	CcSEcCtD
Abacavir—Hypersensitivity—Varenicline—nicotine dependence	0.00694	0.00694	CcSEcCtD
Abacavir—Asthenia—Varenicline—nicotine dependence	0.00676	0.00676	CcSEcCtD
Abacavir—Pruritus—Varenicline—nicotine dependence	0.00667	0.00667	CcSEcCtD
Abacavir—Diarrhoea—Varenicline—nicotine dependence	0.00645	0.00645	CcSEcCtD
Abacavir—Dizziness—Varenicline—nicotine dependence	0.00623	0.00623	CcSEcCtD
Abacavir—Vomiting—Varenicline—nicotine dependence	0.00599	0.00599	CcSEcCtD
Abacavir—Rash—Varenicline—nicotine dependence	0.00594	0.00594	CcSEcCtD
Abacavir—Dermatitis—Varenicline—nicotine dependence	0.00594	0.00594	CcSEcCtD
Abacavir—Headache—Varenicline—nicotine dependence	0.00591	0.00591	CcSEcCtD
Abacavir—Nausea—Varenicline—nicotine dependence	0.0056	0.0056	CcSEcCtD
